HCID 68890408, compound → HCID 69017849, compound

Participants

Reaction Steps

The title compound was prepared using the procedure analogous to that described for EXAMPLE 75, Step E substituting methyl erythro(+/−)-2,3-dihydroxy-3-(4-(4-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoate (from Step A) for methyl 3-(4-(3-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)-3-methylphenyl)propanoate: 1H NMR (500 MHz, CD3OD) δ 1.45 (d, J=6.2, 6H), 2.65 (s, 3H), 4.37 (d, J=5.3, 1H), 4.93-4.96 (m, 2M), 7.40-7.44 (m, 3H), 8.00 (d, J=8.2, 1H), 8.42 (dd, J=2.1, 9.0, 1H), 8.44 (d, J=2.1, 11H).

Provenance & Evidence